Quick Take
Medical device manufacturer Becton, Dickinson and Company (BDX) has agreed to acquire C. R. Bard (BCR) for $24 billion in cash and stock.
Bard sells a range of medical device treatments and products to hospitals and healthcare professionals in North America and abroad.
The bold transaction isn't cheap for BDX shareholders, but based on management's past success with integrating large acquisitions, the outcome is likely a positive one.